Zotepine versus Perazine in Paranoid Schizophrenia: A Double-blind Controlled Trial of Antipsychotic Efficacy;Zotepin versus Perazin bei Patienten mit paranoider Schizophrenie: Eine doppelblind-kontrollierte Wirksamkeitsprüfung

Fortschritte der Neurologie Psychiatrie

Volumn 59, Issue , 1991, Pages 23-29

  Wetzel, H ^a   Bardeleben, U V ^b   Holsboer, F ^c   Benkert, O ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PERAZINE; ZOTEPINE;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PARANOIA; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; COMPARATIVE STUDY; DIBENZOTHIEPINS; DOUBLE-BLIND METHOD; ENGLISH ABSTRACT; FEMALE; HUMAN; MALE; MIDDLE AGE; PERAZINE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA, PARANOID;

EID: 0025743909     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-2007-1000731     Document Type: Article

References (22)

1. AIMS-Abnormal involuntary movement scale. Guy 1976,
2. dt. Version: SKAUB-Skala fúr abnormale unwillkúrliche Bewegungen. Seeler & Kulhanek (1980).
3. Amamolo, H.: Clinical use of zotepine in schizophrenia. Clin. Rep. 14 (1980) 292.
4. Amdp-Arbeitsgemeinschaft fúr Methodik und Dokumentation in der Psychiatrie. Das AMDP-System: Manual zur Dokumentation psychiatrischer Befunde (4. Aufl.) Berlin, Springer (1981).
5. Arikawa, K., I. Yamauchi, H. Mukosa, A. Ishibashi, M. Matsuoka, T. Miura: Clinical experience with zotepine in schizophrenia. Jap. J. Clin. Psychiat. 9 (1980) 101.
6. v. Bardenleben, U., O. Benkert, F. Hotsboer: Clinical and neuroendocrine effects of zotepine. Pharmacopsychiatry 20 (Suppl) (1987) 28-34.
7. v. Bardeleben, U., O. Benkert, F. Holsboer: Antidepressive Wirksamkeit von Zotepin bei Patienten mit endogener Depression, psychotischer Subtyp. Manuskript in Vorbereitung (1988).
8. Benkert, O., H. Hippius: Psychiatrische Pharmakotherapie (4. Aufl.) Berlin, Springer (1986).
9. C/PS-Collegium Internationale Psychiatricae Scalarum (ed.) : Internationale Skalen fúr Psychiatrie. Beltz-Test GmbH, Weinheim (gilt auch fúr CGI, BPRS, FSCL-NL, FSUCL) (1986).
10. Dieterle, D. M., M. Ackenheil, F. Múller-Spahn: Zotepine, a neuroleptic drug with a bipolar therapeutic profile. Pharmacopsychiatry 20 (Suppl.) (1987) 52-57.
11. Fleischhacker, W. W., C. Bamas, C. Stuppäck, B. Unterweger, H. Hinterhuber: Zotepine in the treatment of negative symptoms in chronic schizophrenia. Pharmacopsychiatry 20 (Suppl.) (1987) 5860.
12. Fleischhacker, W. W., C. Bamas, C. Stuppäck, B. Unterweger, H. Hinterhuber: Low dose zotepine in the maintenance treatment of schizophrenia. Pharmacopsychiatry 20 (Suppl.) (1987) 61-63.
13. Fleischhacker, W. W., C. Bamas, C. Stuppäck: Zotepine vs. haloperidol in paranoid schizophrenia: A double-blind trial. Psychopharmacology Bull. 25 (1989) 97-100.
14. Gerlach, J., S. Korsgaard: Classification of abnormal involuntary movements in psychiatric patients. Neuropsychiatr. Clin. 2 (1983) 201-208.
15. Harada, T., S. Otsuki: Antimanic effects of Zotepine. Clin. Therapeutics 8 (1986) 406-414.
16. Klinge Pharma GmbH, wissenschaftliche Informationsbroschúre (1990).
17. Meitzer, H. Y., S. Matsubara, J. C. Lee: Classification of typical and atypical antipsychotic drugs on the basis of dopamine Di, Eh and serotonin2 pKi values. J. Pharmacol. Exp. Ther. 251 (1989) 238246.
18. Múller-Spahn, F.: Extrapyramidalmotorische Nebenwirkungen unter Neuroleptika-Gabe. Diagnostik 19 (1986) 22-26.
19. Sarai, K., M. Okada: Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study. Pharmacopsychiatry 20 (Suppl.) (1987) 38-46.
20. Uchida, S., F. Honda, M. Otsuka, Y. Satoh, J. Mori, T. Ono, M. Hitomie: Pharmacological study of [2-chloro-ll- (2-dimethyl-ami-noethoxy) -dibenzo [b,f] thiepine] (zotepine), a new neuroleptic drug. Arzneimittel-Forsch./Drug Res. 29 (1979) 1588-1594.
21. Wetzel, H., O. Benkert: Neuroleptika: Neue Substanzen - Neue Indikationen. In: Herz, A., H. Hippius, W Spann (eds.) : Psychopharmaka heute. Springer, Berlin (1990) (pp 108-128).
22. Yamawaki, S.: Profiles of clinical efficacy and pharmacological action of zotepine. Pharmacopsychiatry 20 (Suppl.) (1987) 4-7.